Healthcare Nov 19, 2020 09:55 AM (GMT+8) · EqualOcean
Yiou health on November 19, Hengrui pharmaceutical announced that its class 2.2 new drug hr091506 tablets were approved for clinical use. Up to now, there is no same variety listed in China.
Related companies: